Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
4.350
-0.280 (-6.05%)
At close: May 12, 2025, 4:00 PM
4.390
+0.040 (0.92%)
After-hours: May 12, 2025, 7:35 PM EDT
Profound Medical Market Cap
Profound Medical has a market cap or net worth of $128.72 million as of May 12, 2025. Its market cap has decreased by -24.64% in one year.
Market Cap
128.72M
Enterprise Value
86.07M
1-Year Change
-24.64%
Ranking
Category
Stock Price
$4.35
Market Cap Chart
Since October 30, 2019, Profound Medical's market cap has increased from $113.60M to $128.72M, an increase of 13.31%. That is a compound annual growth rate of 2.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 139.10M | -24.89% |
| Dec 31, 2024 | 185.20M | 2.09% |
| Dec 29, 2023 | 181.40M | -20.19% |
| Dec 30, 2022 | 227.30M | -2.53% |
| Dec 31, 2021 | 233.20M | -42.21% |
| Dec 31, 2020 | 403.50M | 210.86% |
| Dec 31, 2019 | 129.80M | 14.26% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |